Custom Health to Go Public Through Merger with Berenson Acquisition

December 28, 2023

🌥️Trending News

Today, Berenson Acquisition ($NYSEAM:BACA) announced that it will be merging with Custom Health in a Special Purpose Acquisition Company (SPAC) transaction, taking the latter public. Berenson Acquisition is a publicly listed company on the New York Stock Exchange (NYSE) with a focus on providing long-term value for its shareholders through strategic investments and acquisitions. The company is led by a team of experienced executives with strong backgrounds in private equity, venture capital, finance, and business development. Custom Health is a leader in the health tech space and specializes in providing mobile health solutions for consumers.

Through this merger, Berenson Acquisition will be able to tap into Custom Health’s customer base and expand its reach in the healthcare industry. The merger between Berenson Acquisition and Custom Health is expected to be finalized by the end of the year, giving investors an opportunity to gain exposure to a growing sector. This is an exciting development for both companies and their shareholders as it will provide long-term value to both entities.

Price History

On Tuesday, BERENSON ACQUISITION announced its intention to go public through a merger with Custom Health, a health provider. The news of the merger sent Berenson Acquisition’s stock soaring, opening at $10.2 and closing at the same price. This merger will allow Custom Health to become a public company, giving them access to more capital and allowing them to expand their business.

In addition, the merger could potentially create a stronger company with improved financials and increased capabilities to meet their customers’ needs. The merger is expected to be finalized in the near future, and investors are encouraged to watch Berenson Acquisition’s stock closely as the deal progresses. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Berenson Acquisition. More…

    Total Revenues Net Income Net Margin
    0 3.7
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Berenson Acquisition. More…

    Operations Investing Financing
    -1.91 271.2 -269.43
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Berenson Acquisition. More…

    Total Assets Total Liabilities Book Value Per Share
    11.41 11.48 -0.01
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Berenson Acquisition are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    FCF Margin ROE ROA
    -15.3% -10.8%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we recently conducted an analysis of BERENSON ACQUISITION‘s wellbeing to determine its health score. The Star Chart revealed that BERENSON ACQUISITION has an intermediate health score of 6/10. This suggests that the company is likely to sustain future operations in times of crisis, while also having enough cashflow and debt to stay afloat. Based on our analysis, BERENSON ACQUISITION is classified as an ‘elephant’, a type of company which has a large amount of assets after deducting off liabilities. This could make BERENSON ACQUISITION attractive to certain kinds of investors seeking a large and stable company. However, our analysis also revealed that BERENSON ACQUISITION is weak in some key areas. These include asset management, dividend payments, growth potential, and profitability. Investors interested in BERENSON ACQUISITION should consider these weaknesses when assessing the company’s long-term prospects. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    The competition between Berenson Acquisition Corp I and its competitors, APx Acquisition Corp I, Colombier Acquisition Corp, and Kimbell Tiger Acquisition Corp, is fierce. All four companies are jockeying for position in the competitive business landscape, looking to gain an edge over their rivals and secure a successful future. As such, each company is examining their strengths and weaknesses and strategizing to stay ahead of the competition.

    – APx Acquisition Corp I ($NASDAQ:APXI)

    APx Acquisition Corp I is a special purpose acquisition corporation (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company has a market cap of 112.74M as of 2023, which is significantly lower than the market average for SPACs. Its Return on Equity of -0.25% is also below the industry average, indicating that the company is not as profitable as other SPACs in the market. Nevertheless, APx Acquisition Corp I is still a viable option for potential investors as it has the potential to generate returns in the long-run.

    Summary

    Berenson Acquisition Corporation, a special purpose acquisition company (SPAC) recently announced a merger with Custom Health, a privately held healthcare company. The merger marks a major development in Custom Health’s journey, allowing the company to go public on the stock exchange. This move is expected to provide Custom Health with access to increased capital and a path to greater growth and expansion. Investors are encouraged to consider this opportunity, as the merger is expected to bring long-term benefits and returns for those who invest. By taking advantage of this merger, investors can benefit from the potential synergies between Berenson Acquisition Corporation and Custom Health’s expanding business model.

    Additionally, Berenson’s expertise in dealing with SPAC mergers provides additional confidence to the investment decision. With the robust growth potential and strong fundamentals of Custom Health, the merger provides a great opportunity for investors to capitalize on market trends and the growing healthcare sector.

    Recent Posts

    Leave a Comment